HomeAll ContractsContract
RADX TECH PROJECT NO. 2643 - PATHOGENDX, INC. - PATHOGENDX COVID-19 MICROARRAY CLADE VARIANT DETECTION TECHNOLOGY
Total Committed
$8.92M
Product or Service Description
Laboratory Testing
Total Potential Value
$8.92M
Contracting Agency
Effective Date
Feb. 22, 2021
Funding Department
NATIONAL INSTITUTES OF HEALTH NHLBI
Type
Firm fixed price
Solicitation Procedure
Only one source
Extent Competed
Not competed
Reason
Only One Source Other (Far 6.302 1 Other)

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
PATHOGENDX TO ADD SUPPLEMENTAL FUNDING FOR RADX TECH PROJECT NO. 2643 - PATHOGENDX, INC. - PATHOGENDX COVID-19 MICROARRAY CLADE VARIANT DETECTION TECHNOLOGY FOR VALIDATION OF COVID-19 VARIANT ANALYSIS May 27, 2021 Funding Only Action $1,342,000
PATHOGENDX RADX TECH PROJECT NO. 2643 - PATHOGENDX, INC. - PATHOGENDX COVID-19 MICROARRAY CLADE VARIANT DETECTION TECHNOLOGY Feb. 22, 2021 $7,577,154
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page